Atlas Trials

Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers

Clinical trial NCT02600442 · UNKNOWN

Trial details

NCT number
NCT02600442
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast NeoplasmsBreast Cancer
Start date
2013-07-01
Primary completion
2016-12-01
Enrollment
168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.